Dr. Rod Ray, CEO and Chairman at Bend Research, discusses his company’s approach to difficult drug delivery challenges and the core technologies offered by his company.
Dr. Jean-Luc Herbeaux, the Head of the Health Care Business Line of Evonik, discusses the rationale and success of his company’s latest acquisition.
EXECUTIVE INTERVIEW – Ezose Sciences: High-Throughput Glycomics for Biomarker Discovery – Bringing Glycan Analysis Into Everyday Research
Scott Siegel, PhD, VP of Business Development at Ezose, discusses how his unique company is catalyzing progress across an emerging research front.
Derek G. Hennecke continues with part 3 of his 6-part series on lessons learned from other industries.
Contributor Cindy H. Dubin interviewed leading players in the prefilled syringe market to find out about their offerings and how they are addressing pharma’s needs for safety, ease of use, cost, and product differentiation.
ANALYTICAL TESTING – Diffusion Kinetics & Permeation Concentration of Human SC Characterization by Terahertz Scanning Reflectometry
Anis Rahman, PhD; Scott Frenchek; Brian Kilfoyle; Leena Patterkine, PhD; Aunik Rahman; and Bozena Michniak- Kohn, PhD; use terahertz reflectometry and spectrometry to investigate the permeation kinetics and concentration profile of active ingredients into the stratum corneum.
Derek G. Hennecke continues with part 2 of his 6-part series on lessons learned from other industries.
Carl Levoguer, PhD, examines how laser diffraction technology has been fashioned to powerfully support every stage of the drug development cycle.
James Burke believes companies adopting ECLM solutions to automate the contract lifecycle would be well advised to understand the business problem they are trying to solve and do the diligence to see where automation makes sense and where it doesn’t for their contracting process.
Bill Martineau, MBA, believes LVPs represent one of the highest value-added applications for pharmaceutical packaging. Nonetheless, demand for IV containers will expand at a lackluster pace due to trends promoting short hospital stays and less-invasive surgeries.
EXCLUSIVE ONLINE CONTENT
Thermo Fisher Scientific Inc. and CSL Limited recently announced they have entered into a strategic partnership to help meet the growing demand for biologic therapies while also….
WEBINAR ALERT- From Diluent to Differentiator: How to Choose a Diluent System That Differentiates Your Lyophilized Product
Along with a rapidly expanding global market for innovative lyophilized biologics come increased cost and competitive pressures. Today, it is critical that….
Taconic Biosciences, a global leader in providing drug discovery animal model solutions, recently announced the successful implementation of its Rapid Restart program….
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
Daré Bioscience, Inc. recently announced that the companies have signed a partnership agreement under which Health Decisions will exclusively provide….